Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 2/20 | 0.35 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.35 |
| ▸ | HRH1 | P35367 | 3/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | THRA | P10827 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.30 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30384929 | 0.99 | FFAR1 (0.34) | FFAR1FFAR4HRH1KCNH2CHRM3 | |
| SCHEMBL30385299 | 0.96 | FFAR1 (0.35) | FFAR1FFAR4HRH1KCNH2CHRM3 | |
| SCHEMBL30385565 | 0.75 | GABRP (0.33) | FFAR1FFAR4EPHX1HRH3 | |
| SCHEMBL30385162 | 0.74 | GABRP (0.32) | EPHX1EPHX2THRATHRB | |
| SCHEMBL23780652 | 0.73 | OPRM1 (0.34) | FFAR1FFAR4HRH1KCNH2HRH3 | |
| SCHEMBL933428 | 0.71 | CHRM3 (0.45) | HRH1KCNH2CHRM3EPHX1EPHX2 | |
| SCHEMBL20977206 | 0.68 | CA2 (0.47) | FFAR1EPHX2THRATHRB | |
| SCHEMBL29089224 | 0.67 | CA2 (0.49) | FFAR1CHRM3EPHX2THRATHRB | |
| SCHEMBL16070684 | 0.66 | LTA4H (0.46) | FFAR1EPHX2 | |
| SCHEMBL5873028 | 0.66 | EPHX1 (0.33) | EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11629157-B2 | Fluoro-boron pyrrole liquid crystal compounds containing 8-(bisphenylethynyl)-ester group flexible multiple ring, preparation method and use thereof | DALIAN UNIVERSITY OF TECHNOLOGY (CN) | 2023-04-18 | — | — | US | claimed |
| US-11629157-B2 | Fluoro-boron pyrrole liquid crystal compounds containing 8-(bisphenylethynyl)-ester group flexible multiple ring, preparation method and use thereof | DALIAN UNIVERSITY OF TECHNOLOGY (CN) | 2023-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11629157-B2 | Fluoro-boron pyrrole liquid crystal compounds containing 8-(bisphenylethynyl)-ester group flexible multiple ring, preparation method and use thereof | CYP46A1, BCL6, DHCR7 | FFAR1 18/4885FFAR4 61/4885HRH1 1782/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.